2018-2023 Global Lung Cancer Market Report (Status and Outlook)

Publisher Name :
Date: 11-Oct-2018
No. of pages: 117

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Lung Cancer market for 2018-2023.

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.

Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.

Over the next five years, LPI(LP Information) projects that Lung Cancer will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Lung Cancer market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

- SCLC Lung Cancer

- NSCLC Lung Cancer

Segmentation by application:

- Hospital & Clinics

- Cancer Research Centers

- Laboratories

We can also provide the customized separate regional or country-level reports, for the following regions:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

- Roche

- Novartis

- Pfizer

- Merck

- Bristol-Myers Squibb

- Eli Lilly And Company

- Sanof

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Lung Cancer market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Lung Cancer market by identifying its various subsegments.

- Focuses on the key global Lung Cancer players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Lung Cancer with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Lung Cancer submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Lung Cancer Market Report (Status and Outlook)

Table of Contents

2018-2023 Global Lung Cancer Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lung Cancer Market Size 2013-2023
2.1.2 Lung Cancer Market Size CAGR by Region
2.2 Lung Cancer Segment by Type
2.2.1 SCLC Lung Cancer 
2.2.2 NSCLC Lung Cancer
2.3 Lung Cancer Market Size by Type
2.3.1 Global Lung Cancer Market Size Market Share by Type (2013-2018)
2.3.2 Global Lung Cancer Market Size Growth Rate by Type (2013-2018)
2.4 Lung Cancer Segment by Application
2.4.1 Hospital & Clinics
2.4.2 Cancer Research Centers
2.4.3 Laboratories
2.5 Lung Cancer Market Size by Application
2.5.1 Global Lung Cancer Market Size Market Share by Application (2013-2018)
2.5.2 Global Lung Cancer Market Size Growth Rate by Application (2013-2018)

3 Global Lung Cancer by Players
3.1 Global Lung Cancer Market Size Market Share by Players
3.1.1 Global Lung Cancer Market Size by Players (2016-2018)
3.1.2 Global Lung Cancer Market Size Market Share by Players (2016-2018)
3.2 Global Lung Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Lung Cancer by Regions
4.1 Lung Cancer Market Size by Regions
4.2 Americas Lung Cancer Market Size Growth
4.3 APAC Lung Cancer Market Size Growth
4.4 Europe Lung Cancer Market Size Growth
4.5 Middle East & Africa Lung Cancer Market Size Growth

5 Americas
5.1 Americas Lung Cancer Market Size by Countries
5.2 Americas Lung Cancer Market Size by Type
5.3 Americas Lung Cancer Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Lung Cancer Market Size by Countries
6.2 APAC Lung Cancer Market Size by Type
6.3 APAC Lung Cancer Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Lung Cancer by Countries
7.2 Europe Lung Cancer Market Size by Type
7.3 Europe Lung Cancer Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Lung Cancer by Countries
8.2 Middle East & Africa Lung Cancer Market Size by Type
8.3 Middle East & Africa Lung Cancer Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Lung Cancer Market Forecast
10.1 Global Lung Cancer Market Size Forecast (2018-2023)
10.2 Global Lung Cancer Forecast by Regions
10.2.1 Global Lung Cancer Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Lung Cancer Forecast by Type
10.8 Global Lung Cancer Forecast by Application

11 Key Players Analysis
11.1 Roche
11.1.1 Company Details
11.1.2 Lung Cancer Product Offered
11.1.3 Roche Lung Cancer Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Roche News
11.2 Novartis
11.2.1 Company Details
11.2.2 Lung Cancer Product Offered
11.2.3 Novartis Lung Cancer Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Novartis News
11.3 Pfizer
11.3.1 Company Details
11.3.2 Lung Cancer Product Offered
11.3.3 Pfizer Lung Cancer Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Pfizer News
11.4 Merck
11.4.1 Company Details
11.4.2 Lung Cancer Product Offered
11.4.3 Merck Lung Cancer Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Merck News
11.5 Bristol-Myers Squibb
11.5.1 Company Details
11.5.2 Lung Cancer Product Offered
11.5.3 Bristol-Myers Squibb Lung Cancer Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Bristol-Myers Squibb News
11.6 Eli Lilly And Company
11.6.1 Company Details
11.6.2 Lung Cancer Product Offered
11.6.3 Eli Lilly And Company Lung Cancer Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Eli Lilly And Company News
11.7 Sanof
11.7.1 Company Details
11.7.2 Lung Cancer Product Offered
11.7.3 Sanof Lung Cancer Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Sanof News
...

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Lung Cancer
Figure Lung Cancer Report Years Considered
Figure Market Research Methodology
Figure Global Lung Cancer Market Size Growth Rate 2013-2023 ($ Millions)
Table Lung Cancer Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of SCLC Lung Cancer 
Table Major Players of NSCLC Lung Cancer
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Lung Cancer Market Size Market Share by Type (2013-2018)
Figure Global Lung Cancer Market Size Market Share by Type (2013-2018)
Figure Global SCLC Lung Cancer  Market Size Growth Rate
Figure Global NSCLC Lung Cancer Market Size Growth Rate
Figure Lung Cancer Consumed in Hospital & Clinics
Figure Global Lung Cancer Market: Hospital & Clinics (2013-2018) ($ Millions)
Figure Global Hospital & Clinics YoY Growth ($ Millions)
Figure Lung Cancer Consumed in Cancer Research Centers
Figure Global Lung Cancer Market: Cancer Research Centers (2013-2018) ($ Millions)
Figure Global Cancer Research Centers YoY Growth ($ Millions)
Figure Lung Cancer Consumed in Laboratories
Figure Global Lung Cancer Market: Laboratories (2013-2018) ($ Millions)
Figure Global Laboratories YoY Growth ($ Millions)
Table Global Lung Cancer Market Size by Application (2013-2018) ($ Millions)
Table Global Lung Cancer Market Size Market Share by Application (2013-2018)
Figure Global Lung Cancer Market Size Market Share by Application (2013-2018)
Figure Global Lung Cancer Market Size in Hospital & Clinics Growth Rate
Figure Global Lung Cancer Market Size in Cancer Research Centers Growth Rate
Figure Global Lung Cancer Market Size in Laboratories Growth Rate
Table Global Lung Cancer Revenue by Players (2016-2018) ($ Millions)
Table Global Lung Cancer Revenue Market Share by Players (2016-2018)
Figure Global Lung Cancer Revenue Market Share by Players in 2017
Table Global Lung Cancer Key Players Head office and Products Offered
Table Lung Cancer Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Lung Cancer Market Size by Regions 2013-2018 ($ Millions)
Table Global Lung Cancer Market Size Market Share by Regions 2013-2018
Figure Global Lung Cancer Market Size Market Share by Regions 2013-2018
Figure Americas Lung Cancer Market Size 2013-2018 ($ Millions)
Figure APAC Lung Cancer Market Size 2013-2018 ($ Millions)
Figure Europe Lung Cancer Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Lung Cancer Market Size 2013-2018 ($ Millions)
Table Americas Lung Cancer Market Size by Countries (2013-2018) ($ Millions)
Table Americas Lung Cancer Market Size Market Share by Countries (2013-2018)
Figure Americas Lung Cancer Market Size Market Share by Countries in 2017
Table Americas Lung Cancer Market Size by Type (2013-2018) ($ Millions)
Table Americas Lung Cancer Market Size Market Share by Type (2013-2018)
Figure Americas Lung Cancer Market Size Market Share by Type in 2017
Table Americas Lung Cancer Market Size by Application (2013-2018) ($ Millions)
Table Americas Lung Cancer Market Size Market Share by Application (2013-2018)
Figure Americas Lung Cancer Market Size Market Share by Application in 2017
Figure United States Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Canada Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Table APAC Lung Cancer Market Size by Countries (2013-2018) ($ Millions)
Table APAC Lung Cancer Market Size Market Share by Countries (2013-2018)
Figure APAC Lung Cancer Market Size Market Share by Countries in 2017
Table APAC Lung Cancer Market Size by Type (2013-2018) ($ Millions)
Table APAC Lung Cancer Market Size Market Share by Type (2013-2018)
Figure APAC Lung Cancer Market Size Market Share by Type in 2017
Table APAC Lung Cancer Market Size by Application (2013-2018) ($ Millions)
Table APAC Lung Cancer Market Size Market Share by Application (2013-2018)
Figure APAC Lung Cancer Market Size Market Share by Application in 2017
Figure China Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Japan Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Korea Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure India Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Australia Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Table Europe Lung Cancer Market Size by Countries (2013-2018) ($ Millions)
Table Europe Lung Cancer Market Size Market Share by Countries (2013-2018)
Figure Europe Lung Cancer Market Size Market Share by Countries in 2017
Table Europe Lung Cancer Market Size by Type (2013-2018) ($ Millions)
Table Europe Lung Cancer Market Size Market Share by Type (2013-2018)
Figure Europe Lung Cancer Market Size Market Share by Type in 2017
Table Europe Lung Cancer Market Size by Application (2013-2018) ($ Millions)
Table Europe Lung Cancer Market Size Market Share by Application (2013-2018)
Figure Europe Lung Cancer Market Size Market Share by Application in 2017
Figure Germany Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure France Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure UK Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Italy Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Russia Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Spain Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Lung Cancer Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Lung Cancer Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Lung Cancer Market Size Market Share by Countries in 2017
Table Middle East & Africa Lung Cancer Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Lung Cancer Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Lung Cancer Market Size Market Share by Type in 2017
Table Middle East & Africa Lung Cancer Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Lung Cancer Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Lung Cancer Market Size Market Share by Application in 2017
Figure Egypt Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Israel Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Lung Cancer Market Size Growth 2013-2018 ($ Millions)
Figure Global Lung Cancer arket Size Forecast (2018-2023) ($ Millions)
Table Global Lung Cancer Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Lung Cancer Market Size Market Share Forecast by Regions
Figure Americas Lung Cancer Market Size 2018-2023 ($ Millions)
Figure APAC Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Europe Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Lung Cancer Market Size 2018-2023 ($ Millions)
Figure United States Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Canada Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Mexico Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Brazil Lung Cancer Market Size 2018-2023 ($ Millions)
Figure China Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Japan Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Korea Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Lung Cancer Market Size 2018-2023 ($ Millions)
Figure India Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Australia Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Germany Lung Cancer Market Size 2018-2023 ($ Millions)
Figure France Lung Cancer Market Size 2018-2023 ($ Millions)
Figure UK Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Italy Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Russia Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Spain Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Egypt Lung Cancer Market Size 2018-2023 ($ Millions)
Figure South Africa Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Israel Lung Cancer Market Size 2018-2023 ($ Millions)
Figure Turkey Lung Cancer Market Size 2018-2023 ($ Millions)
Figure GCC Countries Lung Cancer Market Size 2018-2023 ($ Millions)
Table Global Lung Cancer Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Lung Cancer Market Size Market Share Forecast by Type (2018-2023)
Table Global Lung Cancer Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Lung Cancer Market Size Market Share Forecast by Application (2018-2023)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Lung Cancer Revenue and Gross Margin (2016-2018)
Figure Roche Lung Cancer Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Lung Cancer Revenue and Gross Margin (2016-2018)
Figure Novartis Lung Cancer Market Share (2016-2018)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Lung Cancer Revenue and Gross Margin (2016-2018)
Figure Pfizer Lung Cancer Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Lung Cancer Revenue and Gross Margin (2016-2018)
Figure Merck Lung Cancer Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Lung Cancer Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Lung Cancer Market Share (2016-2018)
Table Eli Lilly And Company Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly And Company Lung Cancer Revenue and Gross Margin (2016-2018)
Figure Eli Lilly And Company Lung Cancer Market Share (2016-2018)
Table Sanof Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanof Lung Cancer Revenue and Gross Margin (2016-2018)
Figure Sanof Lung Cancer Market Share (2016-2018)
  • Global Gerd Drugs And Devices Market Forecast 2018-2026
    Published: 19-Nov-2018        Price: US 2500 Onwards        Pages: 140
    KEY INSIGHTS Gastro-esophageal reflux disease (GERD) is a chronic digestive disorder that occurs due to complications arising in the esophagus. The market is responsible for producing and distributing the drugs and devices required for its optimized cure and accurate diagnosis respectively. The global GERD drug and devices market has been predicted to grow at a CAGR of 1.12% between 2019 and 2027. Market Insights The causes primarily responsible for driving the GERD ......
  • North America Gerd Drugs And Devices Market Forecast 2019-2026
    Published: 19-Nov-2018        Price: US 1250 Onwards        Pages: 92
    Key Findings The North American market for GERD drugs and devices is the largest in the world and is supposed to grow with a 0.78% CAGR for the forecast years 2019-2027. The United States of America and Canada are taken into consideration for the market analysis in this report. Market Insights The rise in initiatives for awareness, education and funding for research on reflux and GERD are helping to proliferate the GERD drugs and devices market in the United States.......
  • Europe Gerd Drugs And Devices Market Forecast 2019-2027
    Published: 19-Nov-2018        Price: US 1250 Onwards        Pages: 88
    Key Findings In 2016, the European market for GERD drugs and devices have been accounted as the largest market worldwide, expected to grow with 0.93% CAGR during the forecasted period 2019-2027. Market Insights The chances of GERD among patients coming for diagnosis at least once per week is in the range of 8.8-25.9 % in Europe which demonstrates the presence of a large number of patients suffering from GERD in this region. Awareness about GERD and usage of self-medi......
  • Asia Pacific Gerd Drugs And Devices Market Forecast 2019-2027
    Published: 19-Nov-2018        Price: US 1250 Onwards        Pages: 85
    Key Findings The APAC region market for GERD drugs and devices account growth of 1.52% CAGR through the forecasted years of 2019-2027. This region includes Japan, China, India, South Korea, Australia and the Rest of Asia. Market Insights The largest revenue contributor to the APAC market for GERD drugs and devices are Japan, China and India because of driving factors like availability of fewer approved drugs to treat GERD and increasing awareness about GERD among the......
  • Global Primary Sclerosing Cholangitis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Primary sclerosing cholangitis (PSC) is a condition causing long-term inflammation and scarring (fibrosis) of bile ducts in the liver. These ducts are tubes that allow the liquid (bile) produced by the liver to pass through the intestine allowing fat digestion. This disease predominantly affects men between the age of 25 and 40 years. The damage to the ducts causes accumulation of bile acids, essential components of bile to build up in the liver leading to liver tissue damage, portal hypertensio......
  • Global Drug Abuse Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Drug Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Alcohol, tobacco, cigarettes, heroin, and marijuana are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of drug abuse. Some commonly used drug for treatment of drugs abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenor......
  • Global Dermatophytic Onychomycosis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 118
    Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails. Scope of the Report: Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has contro......
  • Global Combination Treatment in Aesthetic Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 123
    Combination treatment in aesthetics consists of multiple treatment approaches for improving aesthetic appearance for consumer. It involves both minimally invasive and virtually noninvasive treatment approaches. Combination treatment in aesthetics works on the principle that single modality of treatment cannot offer different advantage each treatment has whereas combination treatment offers best of different treatment. Scope of the Report: Various treatment approaches under......
  • Global Skin Rejuvenation Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Facial rejuvenation is any cosmetic or medical procedure used to increase or restore the appearance of a younger age to human face. Scope of the Report: Skin rejuvenation devices offers non-surgical treatment option for curing variety of skin problem mentioned earlier. They provide visible results in minimum time and less need for invasive technique. Increasing awareness about common skin problems, preference to improve visual / aesthetic appearance, and decreasing device c......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs